ABBOTT VASCULAR DEVICES LIMITED

01833264
Active Maidenhead

Activities of other holding companies n.e.c.

0 employees website.com
Activities of other holding companies n.e.c.
A

ABBOTT VASCULAR DEVICES LIMITED

01833264

Activities of other holding companies n.e.c.

Founded 16 Jul 1984 Active Maidenhead, United Kingdom 0 employees website.com
Activities of other holding companies n.e.c.

Previous Company Names

ABBOTT CARDIOVASCULAR LIMITED 9 May 2002 — 12 Jul 2002
BIOCOMPATIBLES LIMITED 16 Jul 1984 — 9 May 2002
Accounts Submitted 8 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 21 Nov 2025 Next due 30 Nov 2026 5 months remaining
Net assets £-25M £1M 2023 year on year
Total assets £0
Total Liabilities £25M £1M 2023 year on year
Charges 3
3 satisfied

Contact & Details

Contact

Registered Address

Abbott House Vanwall Business Park Vanwall Road Maidenhead Berkshire SL6 4XE

Full company profile for ABBOTT VASCULAR DEVICES LIMITED (01833264), an active company based in Maidenhead, United Kingdom. Incorporated 16 Jul 1984. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2023)

Cash in Bank

N/A

Net Assets

-£24.65M

Decreased by £1.15M (-5%)

Total Liabilities

£24.65M

Increased by £1.15M (+5%)

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Abbott Holdings Ltd
100.0%
4,701,300,329

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Abbott Laboratories

United States Of America

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

ABBOTT VASCULAR DEVICES LIMITED Current Company

Charges

Charges

3 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
15 Dec 2025OfficersTermination of Alison Elizabeth Davies as director on 10 Dec 2025
15 Dec 2025OfficersAppointment of Mr James Wenner as director on 10 Dec 2025
21 Nov 2025Confirmation StatementConfirmation statement made on 16 Nov 2025 with no updates
8 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
1 May 2025OfficersAppointment of Mr Ross Iain Campbell as director on 25 Apr 2025
15 Dec 2025 Officers

Termination of Alison Elizabeth Davies as director on 10 Dec 2025

15 Dec 2025 Officers

Appointment of Mr James Wenner as director on 10 Dec 2025

21 Nov 2025 Confirmation Statement

Confirmation statement made on 16 Nov 2025 with no updates

8 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

1 May 2025 Officers

Appointment of Mr Ross Iain Campbell as director on 25 Apr 2025

Recent Activity

Latest Activity

Termination of Alison Elizabeth Davies as director on 10 Dec 2025

6 months ago on 15 Dec 2025

Appointment of Mr James Wenner as director on 10 Dec 2025

6 months ago on 15 Dec 2025

Confirmation statement made on 16 Nov 2025 with no updates

7 months ago on 21 Nov 2025

Annual accounts made up to 31 Dec 2024

9 months ago on 8 Sept 2025

Appointment of Mr Ross Iain Campbell as director on 25 Apr 2025

1 years ago on 1 May 2025